Agency Forms Undergoing Paperwork Reduction Act Review, 67951-67952 [2021-26005]
Download as PDF
<![CDATA[
67951
Federal Register / Vol. 86, No. 227 / Tuesday, November 30, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–0706]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National
Program of Cancer Registries Program
Evaluation Instrument (NPCR–PEI) to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 26, 2021 to obtain
comments from the public and affected
agencies. CDC received two comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Program of Cancer Registries
Program Evaluation Instrument (NPCR–
PEI) (OMB Control No. 0920–0706, Exp.
02/28/2021)—Reinstatement—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC is responsible for administering
and monitoring the National Program of
Cancer Registries (NPCR). The NPCR
provides technical assistance and
funding, and sets program standards to
assure that complete local, state,
regional, and national cancer incidence
data are available for national and state
cancer control and prevention activities
and health planning activities. The
Program Evaluation Instrument (PEI)
has been used for 28 years to monitor
the performance of NPCR grantees in
meeting the required Program
Standards. CDC currently supports 50
population-based cancer registries (CCR)
in 46 states, two territories, the District
of Columbia, and the Pacific Islands.
The National Cancer Institute supports
the operations of CCRs in the four
remaining states. The Program
Evaluation Instrument (NCPR–PEI)
includes questions about the following
categories of registry operations: (1)
Staffing, (2) legislation, (3)
administration, (4) reporting
completeness, (5) data exchange, (6)
data content and format, (7) data quality
assurance, (8) data use, (9) collaborative
relationships, (10) advanced activities,
and (11) survey feedback. Examples of
information that can be obtained from
various questions include, but are not
limited to: (1) Number of filled staff fulltime positions by position
responsibility; (2) revision to cancer
reporting legislation; (3) various data
quality control activities; (4) data
collection activities as they relate to
achieving NPCR program standards for
data completeness; and (5) whether
registry data is being used for
comprehensive cancer control programs,
needs assessment/program planning,
clinical studies, or incidence and
mortality estimates.
The NPCR–PEI is needed to receive,
process, evaluate, aggregate, and
disseminate NPCR program information.
The information is used by CDC and the
NPCR-funded registries to monitor
progress toward meeting established
program standards, goals, and
objectives; to evaluate various attributes
of the registries funded by NPCR; and to
respond to data inquiries made by CDC
and other agencies of the federal
government. CDC requests OMB
approval for a period of three years to
collect information in the winter of 2022
and 2024, and the new project period
begins July 1, 2022. There are no costs
to the respondents other than their time.
CDC requests approval for an estimated
66 annualized burden hours.
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
NPCR Awardees .............................................
NPCR Awardees .............................................
PEI (Online) ....................................................
REI (Paper) ....................................................
VerDate Sep<11>2014
18:17 Nov 29, 2021
Jkt 256001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\30NON1.SGM
Number of
responses per
respondent
30
3
30NON1
1
1
Average
burden per
response
(in hours)
2
2
67952
Federal Register / Vol. 86, No. 227 / Tuesday, November 30, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–26005 Filed 11–29–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1100]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Identification
of Behavioral and Clinical Predictors of
Early HIV Infection (Project DETECT)’’
to the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on July 12, 2021 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
VerDate Sep<11>2014
18:17 Nov 29, 2021
Jkt 256001
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Identification of Behavioral and
Clinical Predictors of Early HIV
Infection (Project DETECT) (OMB
Control No. 0920–1100, Exp. 1/31/
2022)—Extension—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), National Center for
HIV, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Division of HIV
Prevention (DHP) requests a three-year
Extension for an existing data collection
titled ‘‘Identification of Behavioral and
Clinical Predictors of Early HIV
Infection (Project DETECT).’’
CDC provides guidelines for HIV
testing and diagnosis for the United
States, as well as technical guidance for
its grantees. The purpose of this project
is to assess characteristics of HIV testing
technologies and to update these
guidance documents to reflect the latest
available testing technologies, their
performance characteristics, and
considerations regarding their use.
Specifically, CDC will describe
behavioral and clinical characteristics of
persons with early infection to help HIV
test providers (including CDC grantees)
choose which HIV tests to use, and
target tests appropriately to persons at
different levels of risk. This information
will be disseminated primarily through
guidance documents and articles in
peer-reviewed journals.
The primary study population will be
persons at high risk for, or diagnosed
with HIV infection, many of whom will
be men who have sex with men (MSM),
transgender women, minorities, and
persons who inject drugs (PWIDs)
because the majority of new HIV
infections occur each year among these
populations. The goals of the project are
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
to: (1) Characterize the performance of
new HIV tests for detecting established
and early HIV infection at the point of
care, relative to each other and to
currently used gold standard, non-pointof-care (POC) tests, and (2) identify
behavioral and clinical predictors of
early HIV infection.
Project DETECT will enroll 1,867
persons annually from two study sites
(Seattle and Baltimore). The study will
be conducted in two phases.
Phase 1: After a clinic client consents
to participate, he/she will be assigned a
unique participant ID and will then
undergo testing with up to seven new
HIV tests under study. While awaiting
test results, participants will undergo
additional specimen collections and
complete the Phase 1 Enrollment
Survey.
Phase 2: All Phase 1 participants
whose results on the seven tests under
investigation are not in agreement with
one another (‘‘discordant’’) will be
considered to have a potential early HIV
infection. Nucleic acid amplification
testing that detects viral nucleic acids
will be conducted to confirm an HIV
diagnosis and rule out false positives.
Study investigators expect that each
year, 50 participants with discordant
test results will be invited to participate
in serial follow-up specimen collections
to assess the time point at which all HIV
test results resolve and become
concordant positive (indicating
enrollment during early infection) or
concordant negative (indicating one or
more false-positive test results in Phase
1).
The follow-up schedule will consist
of up to nine visits scheduled at regular
intervals over a 70-day period. At each
follow-up visit, participants will be
tested with the new HIV tests and
additional oral fluid and blood
specimens will also be collected for
storage and use in future HIV test
evaluations at CDC. Participants will be
followed only to the point at which all
their test results become concordant. At
each time point, participants will be
asked to complete the Phase 2 HIV
Symptom and Care survey to collect
information on symptoms associated
with early HIV infection as well as
access to HIV care and treatment since
the last Phase 2 visit. When all tests
become concordant (i.e., at the last
Phase 2 visit) participants will complete
the Phase 2 Behavioral Survey to
identify any behavioral changes during
follow-up. Of the 50 Phase 2
participants; it is estimated that no more
than 26, annually, will have early HIV
infection.
All data for the proposed information
collection will be collected via an
E:\FR\FM\30NON1.SGM
30NON1
]]>Agencies
[Federal Register Volume 86, Number 227 (Tuesday, November 30, 2021)]
[Notices]
[Pages 67951-67952]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26005]
[[Page 67951]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0706]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Program of Cancer Registries Program
Evaluation Instrument (NPCR-PEI) to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on March 26, 2021 to obtain comments from the public and
affected agencies. CDC received two comments related to the previous
notice. This notice serves to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Program of Cancer Registries Program Evaluation Instrument
(NPCR-PEI) (OMB Control No. 0920-0706, Exp. 02/28/2021)--
Reinstatement--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is responsible for administering and monitoring the National
Program of Cancer Registries (NPCR). The NPCR provides technical
assistance and funding, and sets program standards to assure that
complete local, state, regional, and national cancer incidence data are
available for national and state cancer control and prevention
activities and health planning activities. The Program Evaluation
Instrument (PEI) has been used for 28 years to monitor the performance
of NPCR grantees in meeting the required Program Standards. CDC
currently supports 50 population-based cancer registries (CCR) in 46
states, two territories, the District of Columbia, and the Pacific
Islands. The National Cancer Institute supports the operations of CCRs
in the four remaining states. The Program Evaluation Instrument (NCPR-
PEI) includes questions about the following categories of registry
operations: (1) Staffing, (2) legislation, (3) administration, (4)
reporting completeness, (5) data exchange, (6) data content and format,
(7) data quality assurance, (8) data use, (9) collaborative
relationships, (10) advanced activities, and (11) survey feedback.
Examples of information that can be obtained from various questions
include, but are not limited to: (1) Number of filled staff full-time
positions by position responsibility; (2) revision to cancer reporting
legislation; (3) various data quality control activities; (4) data
collection activities as they relate to achieving NPCR program
standards for data completeness; and (5) whether registry data is being
used for comprehensive cancer control programs, needs assessment/
program planning, clinical studies, or incidence and mortality
estimates.
The NPCR-PEI is needed to receive, process, evaluate, aggregate,
and disseminate NPCR program information. The information is used by
CDC and the NPCR-funded registries to monitor progress toward meeting
established program standards, goals, and objectives; to evaluate
various attributes of the registries funded by NPCR; and to respond to
data inquiries made by CDC and other agencies of the federal
government. CDC requests OMB approval for a period of three years to
collect information in the winter of 2022 and 2024, and the new project
period begins July 1, 2022. There are no costs to the respondents other
than their time. CDC requests approval for an estimated 66 annualized
burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
NPCR Awardees......................... PEI (Online)............ 30 1 2
NPCR Awardees......................... REI (Paper)............. 3 1 2
----------------------------------------------------------------------------------------------------------------
[[Page 67952]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-26005 Filed 11-29-21; 8:45 am]
BILLING CODE 4163-18-P
